Calcitonin gene-related peptide (CGRP) inhibitors are a relatively new type of medication approved by the Food and Drug Administration (FDA) to treat and prevent migraines with or without aura. These drugs are biologics - monoclonal antibodies that target CGRP. Lots of crazy side effect questions yet to be answered - cardiovascular, central nervous system, gastrointestinal, skin, renal, .... pretty much everything. Yup, typical phase 4 testing - on the public.
Calcitonin gene-related peptide (CGRP) inhibitors are a relatively new type of medication approved by the Food and Drug Administration (FDA) to treat and prevent migraines with or without aura. These drugs are biologics - monoclonal antibodies that target CGRP. Lots of crazy side effect questions yet to be answered - cardiovascular, central nervous system, gastrointestinal, skin, renal, .... pretty much everything. Yup, typical phase 4 testing - on the public.
At Stake: The Possible Long-Term Side Effects of CGRP Antagonists